Safety of anti-HCV-reactive immunoglobulin in heart transplant patients

Lancet. 1992 Oct 24;340(8826):1039. doi: 10.1016/0140-6736(92)93053-p.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Follow-Up Studies
  • Heart Transplantation*
  • Hepatitis Antibodies / blood*
  • Hepatitis C Antibodies
  • Humans
  • Immunization, Passive*
  • Immunoglobulins, Intravenous / immunology*

Substances

  • Hepatitis Antibodies
  • Hepatitis C Antibodies
  • Immunoglobulins, Intravenous